NCT05458479: Fluoxetine Treatment of Depression in Down Syndrome
- State
- Completed
- Phase
- Phase 4
- People
- 4 taking part
- Started
- 5 Dec 2022
- Primary completion
- 26 Feb 2024
- Arms
- Fluoxetine
- Results
- Posted on the registry
- 14 Jul 2022: Trial registered
- 5 Dec 2022: Trial started
- 26 Feb 2024: Trial completed
- 30 Mar 2025: Trial results posted